Literature DB >> 27081718

Reply to "Wild-type AAV Insertions in Hepatocellular Carcinoma Do Not Inform Debate Over Genotoxicity Risk of Vectorized AAV".

Manfred Schmidt1, Irene Gil-Farina1, Hildegard Büning2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27081718      PMCID： PMC4886948          DOI： 10.1038/mt.2016.48

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  16 in total

1.  DNA sequence motifs which direct adeno-associated virus site-specific integration in a model system.

Authors:  P Meneses; K I Berns; E Winocour
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  Adeno-associated virus Rep-mediated targeting of integrase-defective retroviral vector DNA circles into human chromosome 19.

Authors:  Shuohao Huang; Yoshinori Kawabe; Akira Ito; Masamichi Kamihira
Journal:  Biochem Biophys Res Commun       Date:  2011-11-22       Impact factor: 3.575

3.  Vector design influences hepatic genotoxicity after adeno-associated virus gene therapy.

Authors:  Randy J Chandler; Matthew C LaFave; Gaurav K Varshney; Niraj S Trivedi; Nuria Carrillo-Carrasco; Julien S Senac; Weiwei Wu; Victoria Hoffmann; Abdel G Elkahloun; Shawn M Burgess; Charles P Venditti
Journal:  J Clin Invest       Date:  2015-01-20       Impact factor: 14.808

4.  Targeted integration of functional human ATM cDNA into genome mediated by HSV/AAV hybrid amplicon vector.

Authors:  Maria L Cortés; Angelika Oehmig; Okay Saydam; Jocelyn D Sanford; Katherine F Perry; Cornel Fraefel; Xandra O Breakefield
Journal:  Mol Ther       Date:  2007-11-13       Impact factor: 11.454

5.  Development of animal models for adeno-associated virus site-specific integration.

Authors:  G Rizzuto; B Gorgoni; M Cappelletti; D Lazzaro; I Gloaguen; V Poli; A Sgura; D Cimini; G Ciliberto; R Cortese; E Fattori; N La Monica
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

6.  Adeno-associated virus type 2 wild-type and vector-mediated genomic integration profiles of human diploid fibroblasts analyzed by third-generation PacBio DNA sequencing.

Authors:  Daniela Hüser; Andreas Gogol-Döring; Wei Chen; Regine Heilbronn
Journal:  J Virol       Date:  2014-07-16       Impact factor: 5.103

7.  Targeted integration of a rAAV vector into the AAVS1 region.

Authors:  Peter Ward; Christopher E Walsh
Journal:  Virology       Date:  2012-09-13       Impact factor: 3.616

8.  Site-specific, Rep-mediated integration of the intact beta-globin locus in the human erythroleukaemic cell line K562.

Authors:  S E Howden; L Voullaire; H Wardan; R Williamson; J Vadolas
Journal:  Gene Ther       Date:  2008-05-22       Impact factor: 5.250

9.  A 16-bp RBE element mediated Rep-dependent site-specific integration in AAVS1 transgenic mice for expression of hFIX.

Authors:  Z X Xu; J Z Chen; Y B Yue; J Q Zhang; Z H Li; D M Feng; Z C Ruan; L Tian; J L Xue; Q J Wang; W Jia
Journal:  Gene Ther       Date:  2009-02-26       Impact factor: 5.250

10.  High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions.

Authors:  Jean Charles Nault; Maxime Mallet; Camilla Pilati; Julien Calderaro; Paulette Bioulac-Sage; Christophe Laurent; Alexis Laurent; Daniel Cherqui; Charles Balabaud; Jessica Zucman-Rossi; Jessica Zucman Rossi
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919
View more
  5 in total

1.  Identification of liver-specific enhancer-promoter activity in the 3' untranslated region of the wild-type AAV2 genome.

Authors:  Grant J Logan; Allison P Dane; Claus V Hallwirth; Christine M Smyth; Emilie E Wilkie; Anais K Amaya; Erhua Zhu; Neeta Khandekar; Samantha L Ginn; Sophia H Y Liao; Sharon C Cunningham; Natsuki Sasaki; Martí Cabanes-Creus; Patrick P L Tam; David W Russell; Leszek Lisowski; Ian E Alexander
Journal:  Nat Genet       Date:  2017-06-19       Impact factor: 38.330

Review 2.  Update on clinical gene therapy for hemophilia.

Authors:  George Q Perrin; Roland W Herzog; David M Markusic
Journal:  Blood       Date:  2018-12-17       Impact factor: 22.113

3.  Efficient in vivo base editing via single adeno-associated viruses with size-optimized genomes encoding compact adenine base editors.

Authors:  Jessie R Davis; Xiao Wang; Isaac P Witte; Tony P Huang; Jonathan M Levy; Aditya Raguram; Samagya Banskota; Nabil G Seidah; Kiran Musunuru; David R Liu
Journal:  Nat Biomed Eng       Date:  2022-07-28       Impact factor: 29.234

Review 4.  Advances in genomic hepatocellular carcinoma research.

Authors:  Weitai Huang; Anders Jacobsen Skanderup; Caroline G Lee
Journal:  Gigascience       Date:  2018-11-01       Impact factor: 6.524

5.  Hepatocellular Adenoma in a Patient with Ornithine Transcarbamylase Deficiency.

Authors:  Lin Cheng; Yajuan Liu; Wenjing Wang; J L Merritt; Matthew Yeh
Journal:  Case Reports Hepatol       Date:  2019-10-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.